KDM1A and embryonal neoplasm: The fundamental role of KDM1A in prostate and breast cancer will presumably support a rapid realization of clinical phase I/II studies with KDM1A inhibitors in adults, which will in turn open new avenues for treatment of pediatric embryonal tumors, including medulloblastomas.